You can buy or sell BPTH and other stocks, options, ETFs, and crypto commission-free!
Bio-Path Holdings, Inc. Common Stock, also called Bio-Path Holdings, is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Read More Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
52 Week High
52 Week Low
— per share
Expected Nov 12, After Hours